Investigational Site Number : 3760003

Kefar Sava 4428164

0 studies enrolling now · 1 studies all time

What they study most

Type 1 Diabetes Mellitus

Studies at this site

• Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule — Running, not enrolling